Measuring Treatment Outcome by the Beck Depression Inventory

Richter, Pablo; Werner, Joachim; Bastine, Reiner; Heerlein, Andrés; Kick, Hermes Andreas; Sauer, Heinrich

doi:10.1159/000285052

Cited by 28 publications

(27 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients scoring from 0 to 2 on the mRS were classified as independent in activities of daily living; those scoring 3–5 were categorized as experiencing moderate to severe disability [28]. The total BDI sum scores were grouped into 5 bands that represented normal (<10 patients), mild (11–16 patients), borderline (17–20 patients), moderate (21–30 patients), severe (31–40 patients) and very severe (>40 patients) depressive symptoms [29]. …”

Section: Methodsmentioning

confidence: 99%

Health-Related Quality of Life in Patients with Subarachnoid Haemorrhage

et al. 2010

View full text Add to dashboard Cite

Background: Aneurysmal subarachnoid haemorrhage (SAH) is a devastating disease with high mortality and disability. The data from large longitudinal studies on health-related quality of life (HRQoL) in patients with SAH are limited. The objective was to investigate HRQoL in patients after SAH and to identify predictors of HRQoL. Methods: 113 patients with aneurysmal SAH were assigned to either neurosurgery (n = 57) or endovascular coiling (n = 56). Clinical assessments (Barthel Index, modified Rankin Scale) and evaluation of HRQoL [36-Item Short-Form Survey, EuroQol (EQ5D), EQ visual analogue scale (EQ VAS)] were performed at discharge, and at 6 and 12 months of follow-up. Independent predictors of HRQoL were determined using multiple regression analysis. Results: HRQoL in SAH patients was considerably reduced compared to the normal population. At discharge, 92.2% of the patients had moderate or severe problems on the EQ5D. The EQ VAS score was 57.8 ± 19.3. However, HRQoL still showed improvement from 3 months up to 1 year. At 12 months after SAH, the EQ VAS score was approximately 12–14% higher than at discharge. The independent predictors of decreased HRQoL included female gender, severe SAH, functional disability, depression, a lower level of education and the lack of a stable partnership. Conclusions: The long-term HRQoL outcome after SAH is unfavourable. HRQoL outcome measures should be included in future studies to provide better evidence of the long-term outcomes after SAH. In addition, the independent determinants of HRQoL identified in this study should be considered in the healthcare programmes aimed at increasing the HRQoL in SAH survivors.

show abstract

Section: Methodsmentioning

confidence: 99%

Health-Related Quality of Life in Patients with Subarachnoid Haemorrhage

et al. 2010

View full text Add to dashboard Cite

show abstract

“…It has been shown to correlate with biological markers of depression 93 and to be sensitive to change. 94,95 It also appears to be valid in patients with significant cognitive impairment. 96,97 The scale is generally considered to be in the public domain (see, for example, Table 3 located in Supplementary Materials), but purchase of the scale from the publisher is required for use in large-scale research projects.…”

Section: Beck Depression Inventory (Bdi) Depression In Non-pd Patientsmentioning

confidence: 99%

Depression rating scales in Parkinson's disease: Critique and recommendations

Schrag¹,

Barone²,

Brown³

et al. 2007

Movement Disorders

592

348

View full text Add to dashboard Cite

Depression is a common comorbid condition in Parkinson's disease (PD) and a major contributor to poor quality of life and disability. However, depression can be difficult to assess in patients with PD due to overlapping symptoms and difficulties in the assessment of depression in cognitively impaired patients. As several rating scales have been used to assess depression in PD (dPD), the Movement Disorder Society commissioned a task force to assess their clinimetric properties and make clinical recommendations regarding their use. A systematic literature review was conducted to explore the use of depression scales in PD and determine which scales should be selected for this review. The scales reviewed were the Beck Depression Inventory (BDI), Hamilton Depression Scale (Ham-D), Hospital Anxiety and Depression Scale (HADS), Zung Self-Rating Depression Scale (SDS), Geriatric Depression Scale (GDS), Montgomery-Asberg Depression Rating Scale (MADRS), Unified Parkinson's Disease Rating Scale (UPDRS) Part I, Cornell Scale for the Assessment of Depression in Dementia (CSDD), and the Center for Epidemiologic Studies Depression Scale (CES-D). Seven clinical researchers with clinical and research experience in the assessment of dPD were assigned to review the scales using a structured format. The most appropriate scale is dependent on the clinical or research goal. However, observer-rated scales are preferred if the study or clinical situation permits. For screening purposes, the HAM-D, BDI, HADS, MADRS, and GDS are valid in dPD. The CES-D and CSDD are alternative instruments that need validation in dPD. For measurement of severity of depressive symptoms, the Ham-D, MADRS, BDI, and SDS scales are recommended. Further studies are needed to validate the CSDD, which could be particularly useful for the assessment of severity of dPD in patients with comorbid dementia. To account for overlapping motor and nonmotor symptoms of depression, adjusted instrument cutoff scores may be needed for dPD, and scales to assess severity of motor symptoms (e.g., UPDRS) should also be included to help adjust for confounding factors. The HADS and the GDS include limited motor symptom assessment and may, therefore, be most useful in rating depression severity across a range of PD severity; however, these scales appear insensitive in severe depression. The complex and time-consuming task of developing a new scale to measure depression specifically for patients with PD is currently not warranted.

show abstract

“…The question whether significant changes are due to the therapeutic process or indicate changes in the response behavior or reflect mood changes is discussed by Richter et al [11]. The authors show that changes in the response behavior independent of the therapeutic process can cause a significant reduction in the BDI scores even if the instruction asks for a time frame of at least 1 week.…”

Section: Sensitivity To Changementioning

confidence: 99%

On the Validity of the Beck Depression Inventory

Richter¹,

et al. 1998

Self Cite

View full text Add to dashboard Cite

The present review discusses validity aspects of the Beck Depression Inventory (BDI) on the basis of meta-analyses of studies on the psychometric properties. Shortcomings of the BDI are its high item difficulty, lack of representative norms, and thus doubtful objectivity of interpretation, controversial factorial validity, instability of scores over short time intervals (over the course of 1 day), and poor discriminant validity against anxiety. Advantages of the inventory are its high internal consistency, high content validity, validity in differentiating between depressed and nondepressed subjects, sensitivity to change, and international propagation. The present paper outlines agreements and contradictions between the various studies on the BDI and discusses the potential factors (composition of the subject sample, statistical procedures, point in time of measurement) accounting for the variance in their results.

show abstract

Measuring Treatment Outcome by the Beck Depression Inventory

Cited by 28 publications

References 14 publications

Health-Related Quality of Life in Patients with Subarachnoid Haemorrhage

Health-Related Quality of Life in Patients with Subarachnoid Haemorrhage

Depression rating scales in Parkinson's disease: Critique and recommendations

On the Validity of the Beck Depression Inventory

Contact Info

Product

Resources

About